iRhythm (IRTC) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

IRTC Stock Forecast


iRhythm stock forecast is as follows: an average price target of $144.20 (represents a 88.23% upside from IRTC’s last price of $76.61) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.

IRTC Price Target


The average price target for iRhythm (IRTC) is $144.20 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $198.00 to $110.00. This represents a potential 88.23% upside from IRTC's last price of $76.61.

IRTC Analyst Ratings


Buy

According to 18 Wall Street analysts, iRhythm's rating consensus is 'Buy'. The analyst rating breakdown for IRTC stock is 1 'Strong Buy' (5.56%), 15 'Buy' (83.33%), 2 'Hold' (11.11%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

iRhythm Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 02, 2024Richard NewitterTruist Financial$117.00$75.4455.09%52.72%
Aug 02, 2024Suraj KaliaOppenheimer$145.00$84.2272.17%89.27%
Aug 02, 2024Marie ThibaultBTIG$125.00$84.2248.42%63.16%
Jul 16, 2024Richard NewitterTruist Financial$134.00$102.7630.40%74.91%
Jun 20, 2024Mike PolarkWolfe Research$115.00$98.1617.16%50.11%
May 29, 2024Marie ThibaultBTIG$132.00$87.7750.39%72.30%
May 20, 2024Nathan TreybeckWells Fargo$135.00$94.8342.36%76.22%
Aug 07, 2023Richard NewitterTruist Financial$138.00$111.3123.98%80.13%
Feb 07, 2023-Wells Fargo$150.00$106.8640.36%95.80%
Jan 06, 2023-Morgan Stanley$128.00$88.2045.12%67.08%
Row per page
Go to

The latest iRhythm stock forecast, released on Aug 02, 2024 by Richard Newitter from Truist Financial, set a price target of $117.00, which represents a 55.09% increase from the stock price at the time of the forecast ($75.44), and a 52.72% increase from IRTC last price ($76.61).

iRhythm Price Target by Period


1M3M12M
# Anlaysts-57
Avg Price Target-$127.20$129.00
Last Closing Price$76.61$76.61$76.61
Upside/Downside-100.00%66.04%68.39%

In the current month, the average price target of iRhythm stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to iRhythm's last price of $76.61. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 02, 2024OppenheimerOutperformOutperformHold
Aug 02, 2024BTIGBuyBuyHold
Jun 20, 2024Wolfe Research-OutperformUpgrade
May 29, 2024BTIGBuyBuyHold
May 20, 2024Wells FargoOverweightOverweightHold
May 06, 2024CitigroupBuyBuyHold
Jun 07, 2023CitigroupNeutralNeutralHold
Feb 24, 2023NeedhamBuyBuyHold
Feb 24, 2023William BlairOutperformOutperformHold
Feb 07, 2023Loop Capital Markets-HoldInitialise
Row per page
Go to

iRhythm's last stock rating was published by Oppenheimer on Aug 02, 2024. The company gave IRTC a "Outperform" rating, the same as its previous rate.

iRhythm Financial Forecast


iRhythm Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$124.60M$124.13M$111.44M$112.62M$103.88M-$92.38M$81.80M$85.43M$81.28M$74.31M$78.81M$71.94M$50.88M$63.53M$59.10M$54.67M
Avg Forecast$220.50M$201.21M$201.00M$183.38M$186.73M$173.66M$174.28M$156.32M$158.64M$146.88M$146.15M$128.41M$130.20M$122.61M$120.29M$107.05M$110.26M$105.86M$100.36M$86.76M$78.30M$83.89M$72.71M$70.27M$76.59M$62.34M$42.18M$61.40M$58.42M$53.75M
High Forecast$221.19M$201.84M$201.63M$183.95M$187.32M$174.20M$174.83M$156.80M$159.14M$147.61M$146.61M$128.82M$133.56M$123.64M$120.67M$107.38M$110.60M$106.19M$100.36M$88.11M$79.52M$85.20M$73.84M$71.36M$77.79M$63.31M$42.84M$62.36M$59.33M$54.59M
Low Forecast$219.18M$200.00M$199.79M$182.28M$185.61M$172.62M$173.24M$155.38M$157.69M$146.39M$145.28M$127.64M$129.14M$121.31M$119.57M$106.41M$109.60M$105.23M$100.36M$85.63M$77.28M$82.80M$71.76M$69.35M$75.60M$61.53M$41.63M$60.61M$57.66M$53.05M
# Analysts5454434358545109988434564474435
Surprise %-------------1.02%1.03%1.04%1.02%0.98%-1.06%1.04%1.02%1.12%1.06%1.03%1.15%1.21%1.03%1.01%1.02%

iRhythm's average Quarter revenue forecast for Dec 23 based on 5 analysts is $130.20M, with a low forecast of $129.14M, and a high forecast of $133.56M. IRTC's average Quarter revenue forecast represents a 4.49% increase compared to the company's last Quarter revenue of $124.60M (Sep 23).

iRhythm EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts5454434358545109988434564474435
EBITDA-------------$-27.60M$-18.87M$-33.13M$-19.11M$-20.72M-$-12.24M$-34.12M$-19.00M$-13.11M$-23.75M$-11.82M$-975.00K$-16.77M$-5.62M$-23.16M$-14.51M
Avg Forecast$-48.87M$-44.59M$-44.54M$-40.64M$-41.38M$-38.49M$-38.62M$-34.64M$-35.16M$-32.55M$-32.39M$-59.19M$-28.85M$-27.17M$-26.66M$-53.80M$-24.44M$-26.26M$-22.24M$-48.91M$-36.16M$-23.87M$-18.25M$-20.32M$-11.06M$-1.46M$-17.81M$-7.20M$-17.92M$-11.65M
High Forecast$-48.57M$-44.32M$-44.28M$-40.40M$-41.14M$-38.26M$-38.39M$-34.44M$-34.95M$-32.44M$-32.20M$-47.35M$-28.62M$-26.88M$-26.50M$-43.04M$-24.29M$-21.01M$-22.24M$-39.13M$-28.93M$-19.10M$-14.60M$-16.26M$-8.85M$-1.17M$-14.25M$-5.76M$-14.33M$-9.32M
Low Forecast$-49.02M$-44.73M$-44.68M$-40.77M$-41.51M$-38.61M$-38.75M$-34.75M$-35.27M$-32.71M$-32.49M$-71.02M$-29.60M$-27.40M$-26.74M$-64.57M$-24.51M$-31.51M$-22.24M$-58.70M$-43.39M$-28.65M$-21.90M$-24.38M$-13.27M$-1.75M$-21.38M$-8.64M$-21.50M$-13.98M
Surprise %-------------1.02%0.71%0.62%0.78%0.79%-0.25%0.94%0.80%0.72%1.17%1.07%0.67%0.94%0.78%1.29%1.25%

undefined analysts predict IRTC's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than iRhythm's previous annual EBITDA (undefined) of $NaN.

iRhythm Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts5454434358545109988434564474435
Net Income-------------$-27.12M$-18.48M$-39.11M$-20.20M$-21.45M-$-50.61M$-32.49M$-23.73M$-17.36M$-27.78M$-9.65M$-4.68M$-20.44M$-9.06M$-17.30M$-18.29M
Avg Forecast$-3.24M$-7.23M$-5.99M$-15.12M$-8.51M$-13.38M$-14.32M$-21.32M$-9.77M$-17.78M$-27.83M$-77.11M$-18.02M$-19.82M$-23.72M$-70.10M$-19.48M$-32.81M$-28.35M$-63.73M$-34.43M$-29.83M$-24.16M$-23.76M$-9.03M$-7.02M$-21.71M$-11.62M$-13.38M$-14.69M
High Forecast$-3.21M$-7.17M$-5.94M$-15.00M$-8.44M$-13.27M$-14.21M$-21.16M$-9.69M$-12.93M$-27.61M$-61.69M$-7.51M$-16.52M$-23.53M$-56.08M$-19.33M$-26.25M$-28.35M$-50.98M$-27.55M$-23.86M$-19.33M$-19.01M$-7.22M$-5.61M$-17.37M$-9.29M$-10.71M$-11.75M
Low Forecast$-3.25M$-7.25M$-6.01M$-15.18M$-8.54M$-13.43M$-14.38M$-21.41M$-9.81M$-21.66M$-27.94M$-92.54M$-24.33M$-22.53M$-23.81M$-84.12M$-19.56M$-39.37M$-28.35M$-76.48M$-41.32M$-35.79M$-28.99M$-28.52M$-10.83M$-8.42M$-26.06M$-13.94M$-16.06M$-17.62M
Surprise %-------------1.37%0.78%0.56%1.04%0.65%-0.79%0.94%0.80%0.72%1.17%1.07%0.67%0.94%0.78%1.29%1.25%

iRhythm's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. IRTC's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

iRhythm SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts5454434358545109988434564474435
SG&A-------------$93.77M$91.42M$100.34M$86.73M$80.56M-$73.16M$71.61M$70.75M$62.67M$69.81M$56.29M$49.70M$43.01M$48.23M$53.65M$45.65M
Avg Forecast$176.35M$160.91M$160.75M$146.66M$149.34M$138.88M$139.38M$125.01M$126.88M$117.46M$116.89M$111.47M$104.13M$98.05M$96.20M$101.34M$88.18M$97.81M$80.26M$69.38M$75.90M$67.09M$58.15M$59.72M$52.66M$49.86M$33.74M$49.11M$41.50M$36.65M
High Forecast$176.90M$161.42M$161.25M$147.12M$149.81M$139.32M$139.82M$125.40M$127.27M$118.05M$117.25M$133.77M$106.82M$98.88M$96.51M$121.60M$88.45M$117.37M$80.26M$70.46M$91.08M$68.14M$59.06M$71.66M$63.19M$50.63M$34.26M$49.87M$49.80M$43.98M
Low Forecast$175.29M$159.95M$159.78M$145.78M$148.44M$138.05M$138.55M$124.26M$126.12M$117.07M$116.19M$89.18M$103.28M$97.01M$95.63M$81.07M$87.65M$78.25M$80.26M$68.48M$60.72M$66.22M$57.39M$47.78M$42.13M$49.21M$33.30M$48.47M$33.20M$29.32M
Surprise %-------------0.96%0.95%0.99%0.98%0.82%-1.05%0.94%1.05%1.08%1.17%1.07%1.00%1.28%0.98%1.29%1.25%

iRhythm's average Quarter SG&A projection for Dec 23 is $104.13M, based on 5 Wall Street analysts, with a range of $103.28M to $106.82M. The forecast indicates a 11.05% rise compared to IRTC last annual SG&A of $93.77M (Sep 23).

iRhythm EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts5454434358545109988434564474435
EPS-------------$-0.89$-0.61$-1.29$-0.67$-0.71-$-1.71$-1.10$-0.81$-0.59$-0.95$-0.33$-0.17$-0.75$-0.34$-0.65$-0.74
Avg Forecast$-0.10$-0.23$-0.19$-0.49$-0.27$-0.43$-0.46$-0.68$-0.31$-0.57$-0.89$-0.97$-0.58$-0.64$-0.76$-0.90$-0.63$-0.82$-0.91$-1.10$-1.17$-1.02$-0.94$-0.83$-0.29$-0.51$-0.80$-0.59$-0.53$-0.39
High Forecast$-0.10$-0.23$-0.19$-0.48$-0.27$-0.43$-0.46$-0.68$-0.31$-0.42$-0.89$-0.96$-0.24$-0.53$-0.76$-0.89$-0.62$-0.81$-0.91$-1.08$-1.15$-1.01$-0.93$-0.82$-0.29$-0.50$-0.79$-0.58$-0.52$-0.39
Low Forecast$-0.10$-0.23$-0.19$-0.49$-0.27$-0.43$-0.46$-0.69$-0.31$-0.70$-0.90$-0.98$-0.78$-0.72$-0.76$-0.90$-0.63$-0.82$-0.91$-1.12$-1.19$-1.04$-0.96$-0.85$-0.30$-0.52$-0.82$-0.60$-0.54$-0.40
Surprise %-------------1.40%0.80%1.44%1.07%0.87%-1.56%0.94%0.79%0.63%1.14%1.13%0.33%0.94%0.57%1.23%1.88%

According to undefined Wall Street analysts, iRhythm's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to IRTC previous annual EPS of $NaN (undefined).

iRhythm Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
IRTCiRhythm$76.61$144.2088.23%Buy
OFIXOrthofix Medical$16.76$31.0084.96%-
NPCENeuroPace$7.43$12.8873.35%Buy
FNAParagon 28$7.39$11.5055.62%Buy
SGHTSight Sciences$6.95$10.3348.63%Hold
LIVNLivaNova$48.53$71.2546.82%Buy
CNMDCONMED$75.40$101.0033.95%Buy
KIDSOrthoPediatrics$32.28$40.8026.39%Buy
BRKRBruker$65.66$71.679.15%Buy
ITGRInteger$126.78$131.003.33%Buy
SRDXSurmodics$39.36$39.500.36%Buy
GKOSGlaukos$126.28$101.56-19.58%Buy

IRTC Forecast FAQ


Yes, according to 18 Wall Street analysts, iRhythm (IRTC) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 15 'Buy' recommendations, accounting for 88.89% of IRTC's total ratings.

iRhythm (IRTC) average price target is $144.2 with a range of $110 to $198, implying a 88.23% from its last price of $76.61. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for IRTC stock, the company can go up by 88.23% (from the last price of $76.61 to the average price target of $144.2), up by 158.45% based on the highest stock price target, and up by 43.58% based on the lowest stock price target.

IRTC's average twelve months analyst stock price target of $144.2 supports the claim that iRhythm can reach $110 in the near future.

iRhythm's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $690.98M (high $693.15M, low $686.84M), average EBITDA is $-153M (high $-152M, low $-154M), average net income is $-57.534M (high $-57.086M, low $-57.768M), average SG&A $552.61M (high $554.34M, low $549.3M), and average EPS is $-1.847 (high $-1.833, low $-1.855). IRTC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $806.08M (high $808.61M, low $801.26M), average EBITDA is $-179M (high $-178M, low $-179M), average net income is $-31.569M (high $-31.323M, low $-31.697M), average SG&A $644.66M (high $646.68M, low $640.8M), and average EPS is $-1.014 (high $-1.006, low $-1.018).

Based on iRhythm's last annual report (Dec 2022), the company's revenue was $410.92M, beating the average analysts forecast of $403.23M by 1.91%. Apple's EBITDA was $-85.14M, missing the average prediction of $-122M by -30.13%. The company's net income was $-116M, missing the average estimation of $-144M by -19.55%. Apple's SG&A was $322.2M, missing the average forecast of $335.63M by -4.00%. Lastly, the company's EPS was $-3.88, beating the average prediction of $-3.453 by 12.35%. In terms of the last quarterly report (Sep 2023), iRhythm's revenue was $124.6M, beating the average analysts' forecast of $122.61M by 1.63%. The company's EBITDA was $-27.603M, beating the average prediction of $-27.172M by 1.59%. iRhythm's net income was $-27.116M, beating the average estimation of $-19.823M by 36.79%. The company's SG&A was $93.77M, missing the average forecast of $98.05M by -4.37%. Lastly, the company's EPS was $-0.89, beating the average prediction of $-0.636 by 39.84%